Abbott previously issued a voluntary medical device correction about this problem, but no recall had been announced at that time. The recall includes devices distributed from November 2017 to February 2023.
This new approach, which combines traditional intermittent fasting with 20-hour fasting periods on nonconsecutive days, could make a big impact on the cardiovascular health of high-risk patients.
According to an advisory on the FDA’s website, there is a “reasonable probability” that any immunocompromised patients exposed to the affected antibiotic could develop a life-threatening infection.
Eric Secemsky, MD, told Cardiovascular Business that a lack of training is one of the biggest factors limiting the use of intravascular imaging-guided PCI among interventional cardiologists.
Commissural alignment is especially important now, researchers explained, because TAVR is being recommended for younger patients with longer life expectancies.